Follow-up Study to Evaluate the Safety and Immunogenicity of a HPV Vaccine (580299) in North America
NCT00546078
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
116
Enrollment
INDUSTRY
Sponsor class
Conditions
Infections, Papillomavirus
Interventions
BIOLOGICAL:
Cervarix™
Sponsor
GlaxoSmithKline